JPRN-UMIN000000955已完成1 期
Cancer therapy with vaccination using HLA-A24-restricted peptide from URLC10:a phase I study in patient with unresectable esophageal cancer - URLC10 peptide vaccination: a phase I study in patients with unresectable esophageal cancer
Institute of Medical Science The University of Tokyo0 个研究点目标入组 6 人开始时间: 2007年12月24日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •pregnancy uncontroled infection uncontroled cerebral metastasis etc
研究者
相似试验
已完成
1 期
Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000000702Institute of Medical Science, University of Tokyo6
已完成
1 期
Cancer therapy with vaccination using HLA-A24-restricted peptide from TOMM34:a phase I study in patients with unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000000782Institute of Medical Science, University of Tokyo6
已完成
不适用
Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000000704Institute of Medical Science, University of Tokyo6
已完成
1 期
Cancer specific vaccine therapy using HLA-A24 restricted epitope-peptide for patients with advanced metastatic colorectal cancer.PhaseI/II clinical trial.colorectal cancerJPRN-UMIN000004994Hokkaido Cancer Center30
已完成
1 期
Cancer vaccine therapy with HLA-A24 restricted epitope peptide cocktail for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.Advanced metastatic colorectal cancersJPRN-UMIN000004959Tokai University School of Medicine30